(TTP) TD Canadian Equity Index - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA87240Y1025 • Canadian Equity
TTP: Stocks, Bonds, Canadian Equities
The TD Canadian Equity Index ETF (TTP) is a straightforward, low-cost investment vehicle designed to track the performance of the Morningstar Canada GR CAD Index. This index is a broad measure of Canadian equities, covering a diverse range of sectors, including financials, energy, and technology. The fund is domiciled in Canada and listed on the Toronto Stock Exchange (TSX), making it a convenient option for investors looking for exposure to the Canadian market.
With an assets under management (AUM) of approximately 2.56 billion CAD, the ETF offers a scale that ensures liquidity and operational efficiency. While specific valuation metrics like P/E, P/B, and P/S are not disclosed for the fund itself, the underlying index provides exposure to a mix of large-cap and mid-cap Canadian companies. This makes it a suitable option for investors seeking broad market exposure without the need for individual stock selection.
From a structural perspective, the ETF employs a passive investment approach, aiming to replicate the performance of its underlying index. This typically involves holding a representative sample of the indexs constituents, weighted according to their market capitalization. The funds expense ratio, while not explicitly mentioned here, is generally competitive with other index-tracking ETFs in the Canadian market.
For investors and fund managers, the key consideration is understanding the composition and valuation of the Morningstar Canada GR CAD Index. While the ETF itself does not provide explicit P/E or P/B ratios, the indexs valuation metrics can be analyzed to gauge the attractiveness of the Canadian equity market at any given time. Additionally, the funds tracking error and dividend yield are important factors for investors evaluating its suitability for their portfolios.
Ultimately, the TD Canadian Equity Index ETF (TTP) serves as a tool for gaining efficient exposure to the Canadian equity market. Its appeal lies in its simplicity, transparency, and alignment with the performance of the broader Canadian economy. For long-term investors seeking diversification or a core Canadian equity allocation, this ETF warrants consideration alongside other similar offerings in the market.
Additional Sources for TTP ETF
TTP ETF Overview
Market Cap in USD | 1,917m |
Category | Canadian Equity |
IPO / Inception | 2016-03-22 |
TTP ETF Ratings
Growth Rating | 82.8 |
Fundamental | - |
Dividend Rating | 62.3 |
Rel. Strength | 5.46 |
Analysts | - |
Fair Price Momentum | 29.20 CAD |
Fair Price DCF | - |
TTP Dividends
Dividend Yield 12m | 2.64% |
Yield on Cost 5y | 5.16% |
Annual Growth 5y | 5.13% |
Payout Consistency | 94.0% |
TTP Growth Ratios
Growth Correlation 3m | -74.9% |
Growth Correlation 12m | 81.5% |
Growth Correlation 5y | 90.2% |
CAGR 5y | 14.66% |
CAGR/Max DD 5y | 0.89 |
Sharpe Ratio 12m | 2.35 |
Alpha | 8.39 |
Beta | 0.582 |
Volatility | 24.95% |
Current Volume | 16.1k |
Average Volume 20d | 29.7k |
As of April 25, 2025, the stock is trading at CAD 28.33 with a total of 16,077 shares traded.
Over the past week, the price has changed by +2.31%, over one month by -1.88%, over three months by -2.09% and over the past year by +15.70%.
Yes. Based on ValueRay Analyses, TD Canadian Equity Index (TO:TTP) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 82.82 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TTP as of April 2025 is 29.20. This means that TTP is currently overvalued and has a potential downside of 3.07%.
TD Canadian Equity Index has no consensus analysts rating.
According to ValueRays Forecast Model, TTP TD Canadian Equity Index will be worth about 32.2 in April 2026. The stock is currently trading at 28.33. This means that the stock has a potential upside of +13.7%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 32.2 | 13.7% |